Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review). | Int J Oncol | 2023 | 36367195 | PubTator, text mining | PubMed |
| EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes. | Nucleic Acids Res | 2023 | 36350659 | PubTator, text mining | PubMed |
| N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer. | Transl Oncol | 2023 | 36327698 | PubTator, text mining | PubMed |
| Research progress of m6A methylation in prostate cancer. | Asian J Androl | 2023 | 36308073 | PubTator, text mining | PubMed |
| Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer. | Cancer Med | 2023 | 36281556 | PubTator, text mining | PubMed |
| Biological roles of adenine methylation in RNA. | Nat Rev Genet | 2023 | 36261710 | PubTator, text mining | PubMed |
| RNA m6 A methylation in cancer. | Mol Oncol | 2023 | 36260366 | PubTator, text mining | PubMed |
| Methylation of N6 adenosine-related long noncoding RNA: effects on prognosis and treatment in 'driver-gene-negative' lung adenocarcinoma. | Mol Oncol | 2023 | 36221911 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma. | IUBMB Life | 2023 | 36177774 | PubTator, text mining | PubMed |
| Effects of writers, erasers and readers within miRNA-related m6A modification in cancers. | Cell Prolif | 2023 | 36162823 | PubTator, text mining | PubMed |
| M6AREG: m6A-centered regulation of disease development and drug response. | Nucleic Acids Res | 2023 | 36134713 | PubTator, text mining | PubMed |
| Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer. | J Cancer Res Clin Oncol | 2023 | 36048273 | PubTator, text mining | PubMed |
| N6-methyladenosine and Its Implications in Viruses. | Genomics Proteomics Bioinformatics | 2023 | 35835441 | PubTator, text mining | PubMed |
| Identification and functional analysis of N6-methyladenine (m6 A)-related lncRNA across 33 cancer types. | Cancer Med | 2023 | 35789547 | PubTator, text mining | PubMed |
| m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | 35780396 | PubTator, text mining | PubMed |
| Construction and validation of a nomogram based on N6-Methylandenosine-related lncRNAs for predicting the prognosis of non-small cell lung cancer patients. | Cancer Med | 2023 | 35726651 | PubTator, text mining | PubMed |
| Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. | Cancer Med | 2023 | 35668574 | PubTator, text mining | PubMed |
| Characteristics of N6-methyladenosine Modification During Sexual Reproduction of Chlamydomonas reinhardtii. | Genomics Proteomics Bioinformatics | 2023 | 35550876 | PubTator, text mining | PubMed |
| Specific Regulation of m6A by SRSF7 Promotes the Progression of Glioblastoma. | Genomics Proteomics Bioinformatics | 2023 | 34954129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=22